Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.39
- Piotroski Score 4.00
- Grade Neutral
- Symbol (BOLT)
- Company Bolt Biotherapeutics, Inc.
- Price $0.67
- Changes Percentage (1.67%)
- Change $0.01
- Day Low $0.66
- Day High $0.67
- Year High $1.56
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.
- Last Earnings 08/13/2014
- Ex-Dividend for 5/16 Dividend 08/29/2014
- Dividend Payable 10/02/2014
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $1.00
- High Stock Price Target $1.00
- Low Stock Price Target $1.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.66
- Trailing P/E Ratio -0.46
- Forward P/E Ratio -0.46
- P/E Growth -0.46
- Net Income $-69,197,000
Income Statement
Quarterly
Annual
Latest News of BOLT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Yankees Could Have In-Town Backup Plan If Juan Soto Bolts In Free Agency
The New York Yankees are facing key decisions this offseason after narrowly missing their 28th World Series title. The potential signing of Juan Soto could impact their strategy, possibly leading to p...
By Newsweek | 1 day ago -
Bolton: Trump criticism of Liz Cheney stems from Jan. 6
John Bolton expressed that Donald Trump's criticism of Liz Cheney is rooted in her vote to impeach him after January 6th, rather than her hawkish stance. Cheney faced backlash from Trump for her stanc...
By The Hill | 3 days ago -
Apple Launches New Macbook Pro Models With Powerful M4 Chips and Thunderbolt 5 Support
Apple introduced the latest MacBook Pro models with the new M4 chip family, focusing on AI integration and improved performance. The M4 CPUs promise enhanced speed, graphics, and memory capabilities, ...
By Yahoo! Finance | 6 days ago
